openPR Logo
Press release

Investigation announced for Long-Term Investors in Natera, Inc. (NASDAQ: NTRA)

03-18-2022 01:59 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Natera, Inc. (NASDAQ: NTRA) shares over potential wrongdoing at Natera, Inc.

An investigation on behalf of investors in Natera, Inc. (NASDAQ: NTRA) shares over potential wrongdoing at Natera, Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Natera, Inc.

Investors who purchased shares of Natera, Inc. (NASDAQ: NTRA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Natera, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Carlos, CA based Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Natera, Inc. reported that its annual Total Revenue rose from $302.32 million in 2019 to $391 million in 2020, and that its Net Loss increased from $124.82 million in 2019 to $216.27 million in 2020.
On January 1, 2022, an article from the New York Times called into question the accuracy of certain prenatal tests, alleging that positive results on tests are incorrect about 85 percent of the time, and that patients who receive a positive result are supposed to pursue follow-up testing, which "can cost thousands of dollars, come with a small risk of miscarriage and can't be performed until later in pregnancy."

Shares of Natera, Inc. (NASDAQ: NTRA) declined from $96.80 per share on December 17, 2021, to as low as $61.03 per share on January 19, 2022.

Those who purchased shares of Natera, Inc. (NASDAQ: NTRA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Natera, Inc. (NASDAQ: NTRA) here

News-ID: 2581632 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Natera

Investigation for Long-Term Investors in Natera, Inc. (NASDAQ: NTRA) over potent …
An investigation was announced for current long-term investors in shares of Natera, Inc. (NASDAQ: NTRA) concerning potential breaches of fiduciary duties by certain directors and officers of Natera, Inc. Investors who are current long term investors in Natera, Inc. (NASDAQ: NTRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors in shares of Natera, Inc. (NASDAQ: NTRA)
An investor, who purchased shares of Natera, Inc. (NASDAQ: NTRA), filed a lawsuit over alleged Securities Laws violations by Natera, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Natera, Inc. (NASDAQ: NTRA) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2022. NASDAQ: NTRA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Prenatal Genetic Testing Market 2019 | Sequenom Laboratories, Illumina, Natera, …
Prenatal Genetic Testing Research Report contains all Analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry. Download PDF Sample of this Report @ http://www.supplydemandmarketresearch.com/home/contact/83889?ref=Sample-and-Brochure&toccode=SDMRME83889&utm_source=S2 The key players covered in this study Sequenom Laboratories Illumina Natera Ariosa Diagnostics BGI Health Natera LifeCodexx and more... Market segment by Type, the product can be split into Diagnostic Test Chorionic Villi Sampling (CVS) Amniocentesis
Prenatal Genetic Testing Industry 2019-2025 Global Market Share, Segments, Manuf …
This study estimates the factors that are boosting the development of the global Prenatal Genetic Testing market, on the basis of key principles segments such as end-users, application, product, technology, and region are surveyed comprehensively. A thorough examination has been done in this report to bring about the share and position. In the report, a complete analysis of the growth revenue is offered. Get Sample copy @ https://www.orianresearch.com/request-sample/802116 Analysis of Key Manufacturers: • Sequenom
Pre Pregnancy Genetic Testing Market Analysis 2025: Top Players - Ariosa Diagnos …
The Pre Pregnancy Genetic Testing Market Research Report Provided By Crystal Market Research (CMR) Is The Most Detailed Study About Pre Pregnancy Genetic Testing That Is Estimated To Grow At A Tremendous Rate Over The Forecast Period 2018-2025 Summary: Pre-Pregnancy Genetic Testing Market By Test Type (Screening Test (Maternal Serum Quad Screening, Sequential Screening & Carrier Screening) and Diagnostic Test (Fetal Biopsy, Placental Biopsy, Cordocentesis, Amniocentesis & Chorionic Villi Samplin)) and End
Pre-Pregnancy Genetic Testing Market Size With Major Eminent Players: Ariosa Dia …
The detailed report of Pre-Pregnancy Genetic Testing Market evaluated by skilled experts is segmented into Application and Product. The Pre-Pregnancy Genetic Testing Market is anticipated to witness considerable development in the following years from 2018-2025. In order to BROWSE complete report with TOC: https://www.crystalmarketresearch.com/report/pre-pregnancy-genetic-testing-market . Industry Outlook: Pre-Pregnancy Genetic Testing is carried out for analyzing genetic disorders if any, if tested negative the couple is reassured that the child born will have small